Skip to main content
SpringerLink
Log in

Diffuse interstitial lung diseases

  • Chapter
Book cover Nuclear medicine and lung diseases

  • 51 Accesses

Abstract

Diffuse interstitial lung diseases (ILD) constitute a heterogenous group of processes which have in common reticular or nodular, reticulonodular or linear patterns on chest roentgenogram. They are characterized by a diffuse infiltration of alveolar walls by inflammatory or malignant cells, connective tissue or fluid. About 100 entities have been ascribed to diffuse interstitial lung disease. The aim of the clinician is to confirm the diagnosis of ILD, to elicit an entity from history, symptoms, physical examination, chest roentgenogram, pulmonary function and laboratory data in order to plan treatment. Therefore, the pattern may include malignant, infectious, and cardiac diseases with roentgenographic reticulonodular patterns, i.e lymphangitic carcinomatosis, alveolar cell carcinoma, miliary tuberculosis, infection in immunosuppressed patients, and congestion of the lungs secondary to congestive heart failure. In fact, the term ILD usually excludes this heterogenous group of diseases and is focused on inflammatory processes in which the common outcome is dominated by fibrotic lung disorder. They are also commonly called pulmonary fibrosis and will be developed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. De Remee RA (1987) Diffuse interstitial pulmonary disease from the perspective of the clinician. Chest 92: 1068–1073.

    Article  Google Scholar 

  2. Cherniack RM, Crystal RG, Kalica AR (1991) Current concepts in idiopathic pulmonary fibrosis: a road map for the future. Am Rev Respir Dis 143: 680–683.

    Article  CAS  PubMed  Google Scholar 

  3. Tsan MF (1985) Mechanism of Gallium-67 accumulation in inflammatory lesions. J Nucl Med 26: 88–92.

    CAS  PubMed  Google Scholar 

  4. Okhubo Y, Sawamura H, Katoh S, Sasayama A, Abe K, Kohno H, Kubodera A (1990) Studies on Gallium-67 uptake by mouse granuloma tissues. Nucl Med Biol 18: 205–208.

    Google Scholar 

  5. Hoffer P (1980) Gallium: Mechanisms. J Nucl Med 21: 282–285.

    CAS  PubMed  Google Scholar 

  6. Bekerman C, Hoffer PB, Bitran JD, Gupta RG (1980) Gallium-67 citrate imaging studies of the lung. Sem Nucl Med 10: 286–301.

    Article  CAS  Google Scholar 

  7. Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ (1990) Recognition of distinctive patterns of Gallium-67 distribution in sarcoidosis. J Nucl Med 31: 1909–1914.

    CAS  PubMed  Google Scholar 

  8. Gupta RG, Bekerman C, Sicilian L, Oparil S, Pinsky SM, Szidon JP (1982) Gallium-67 citrate scanning and serum angiotensin converting enzyme levels in sarcoidosis. Radiology 144: 895–899.

    CAS  PubMed  Google Scholar 

  9. Klech H, Köhn H, Kummer F, Mostbeck A (1982) Assessment of activity in sarcoidosis. Chest 82:732–738.

    Article  CAS  PubMed  Google Scholar 

  10. Köhn H, Klech H, Mostbeck A, Kummer F (1982) Gallium-67 scanning for assessment of disease activity and therapy decisions in pulmonary sarcoidosis in comparison to chest scintigraphy, serum ACE and blood T-lymphocytes. Eur J Nucl Med 7:413–416.

    Article  PubMed  Google Scholar 

  11. Nosal A, Schleissner LA, Mishkin FS (1979) Angiotensin-I-converting enzyme and Gallium scan in non-invasive evaluation of sarcoidosis. Ann Intern Med 90: 328–331.

    Article  CAS  PubMed  Google Scholar 

  12. Gupta RG, Bekerman C, Catchatourian R et al (1979) Relationship between bronchoalveolar cellular analysis and Gallium-67 citrate uptake in active sarcoidosis (abstr). Clin Res 27: 622A.

    Google Scholar 

  13. Baughman RP, Fernandez M, Bosken CH, Mantil J, Hurtubise P (1984) Comparison of Gallium-67 scanning, bronchoalveolar lavage and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Am Rev Respir Dis 129: 676–681.

    CAS  PubMed  Google Scholar 

  14. Klech H, Köhn H, Huppmann M, Pohl W (1987) Thoracic imaging with Gallium-67. Eur J Nucl Med 13: S24–S36.

    Article  PubMed  Google Scholar 

  15. Van Unnik JG, van Royen EA, Alberts C, van der Schott JB (1983) A method of quantitative Gallium-67 scintigraphy in the evaluation of pulmonary sarcoidosis. Eur J Nucl Med 8: 351–353.

    Article  PubMed  Google Scholar 

  16. Bourguet P, Delavai Ph, Herry JY (1986) Direct quantitation of thoracic Gallium-67 uptake in sarcoidosis. J Nucl Med 27: 1550–1556.

    CAS  PubMed  Google Scholar 

  17. Crystal RG, Bitterman PB, Rennard DI, Hance AJ, Keogh BA (1984). Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310: 154-166, 235–244.

    Article  CAS  PubMed  Google Scholar 

  18. Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB (1978). Normal chest roentgenograms in chronic diffuse infiltration lung disease. N Engl J Med 298: 934–939.

    Article  CAS  PubMed  Google Scholar 

  19. Watters LC, Schwartz MI, Cherniack RM (1987) Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituants and their relationships with histopathology and clinical response to therapy. Am Rev Respir 135: 696–704.

    CAS  Google Scholar 

  20. Stoller JK, Rankin JA, Reynolds HY (1987) The impact of broncho-alveolar lavage cell analysis on clinician’s diagnostic reasoning about interstitial lung diseases. Chest 92: 839–843.

    Article  CAS  PubMed  Google Scholar 

  21. Muller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN (1987) Disease activity in idiopathic pulmonary fibrosis: computed tomography-pathologic correlation. Radiology 165: 731–734.

    CAS  PubMed  Google Scholar 

  22. Grenier P, Valeyre D, Cluzel P, Brauner MW, Lenoir S, Chastang C (1991) Chronic diffuse infiltration lung disease: assessment of diagnostic value of chest radiography and high-resolution CT. Radiology 179: 123–132.

    CAS  PubMed  Google Scholar 

  23. Begin CJ, Müller NL (1985) CT in the diagnosis of interstitial lung disease. AJR 145: 505–510.

    Google Scholar 

  24. Genereux GP (1975) The end stage lung. Pathogenesis, pathology, and radiology. Radiology 116: 279–289.

    CAS  PubMed  Google Scholar 

  25. Caillat-Vigneron N, Moretti JL, Valeyre D, Le Guludec D, Sadoun D, Battesti JP (1990) Pulmonary epithelial permeability versus 67Ga uptake in chronic interstitial lung disease (CILD) (abstr). Eur J Nucl Med 16: S150.

    Google Scholar 

  26. Harrison NK, Glanville AR, Strickland B, Haslam PL, Corrin B, Addis BJ, Lawrence R, Millar AB, Black CM, Turner-Warwick M (1987) Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearence. Respir Med 83: 403–414.

    Article  Google Scholar 

  27. Leatherman JW, Davies SF, Hoidal JR (1984) Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine 63: 343–361.

    Article  CAS  PubMed  Google Scholar 

  28. Bonnotte B, Chantereau MJ, Lorcerie B, Chauffert B, Noblet JF, Chalopin JM, Martin F (1992) Hemmorragies intra-alvéolaires au cours des maladies systémiques. Presse Med 21: 839–842.

    CAS  PubMed  Google Scholar 

  29. Leatherman JW (1987) Immune alveolar haemorrhage. Chest 91: 891–897.

    Article  CAS  PubMed  Google Scholar 

  30. Macklem PT, Thurlbeck WM, Fraser RG (1971) Chronic obstructive disease in small airways. Ann Intern Med 74: 167–177.

    Article  CAS  PubMed  Google Scholar 

  31. Epier GR, Colby TV (1983) The spectrum of bronchiolitis obliterans. Chest 83: 161–162.

    Article  Google Scholar 

  32. Cordier JF, Loire R, Peyrol S (1991) Bronchiolitis obliterans organizing pneumonia. Originalité et limites d’une entité anatomo-clinique. Rev Mal Resp 8: 139–152.

    CAS  Google Scholar 

  33. Cordier JF, Moulin J, Brune J, Moulin G, Touraine R (1981) Accidents respiratoires au cours de traitements par la D Pénicillamine: alévolites et bronchiolites. Rev Fr Mal Resp 9: 319–326.

    CAS  Google Scholar 

  34. Strimlan CV, Rosenow EC, Divertie MB (1976) Pulmonary manifestations of Sjögren’s syndrome. Chest 70: 354–361.

    Article  CAS  PubMed  Google Scholar 

  35. Newball HD, Brahim SA (1977) Chromc obstructive airway disease in patients with Sjögren’s syndrome. Am Rev Resp Dis 115: 295–304.

    CAS  PubMed  Google Scholar 

  36. Schwartz MI, Matthay RA, Sahn SA, Stanford RE, Mamorstein BL, Scheinlorn DF (1976) Interstitial disease in polymyositis and dermatomyositis: an analysis of 6 cases and review of the literature. Medicine 55: 89–104.

    Article  Google Scholar 

  37. Siemsen JK, Sargent EN, Grebe SF, Winsor DW, Wentz D, Jacobsen G (1974) Pulmonary concentration of Gallium-67 in pneumoconiosis. Am J Roentgenol Radium Ther Nuc Med 120: 815–820.

    Article  CAS  Google Scholar 

  38. Hmama Z, Normier G, Kouassi E, Flacher M, Binz H, Revillard JP, (1992) Binding of a membrane proteoglycan from Klebsiella pneumoniae and its chemically-defined derivatives to human leukocytes. Immunobiology (in press).

    Google Scholar 

  39. Hmama Z, Lina G, Normier G, Binz H, Revillard JP (1992) Monocyte cytokine secretion induced by chemically-defined derivatives of Klebsiella pneumoniae. Clin Exp Immunol (in press).

    Google Scholar 

  40. Perrin F, Pittet JC, Hoffschir D, Normier G, Binz H, Le Pape A, (1993) Scintigraphic potential of J001X acylated poly-galactoside for the imaging of inflammatory lesions in pigs. Nucl Med Biol (in press).

    Google Scholar 

  41. Diot P, Le Pape A, Nolibe D, Normier G, Binz H, Revillard JP, Lasfargues G, Lavandier M, Lemarié E (1992) Scintigraphy with J001X, a Klebsiella membrane glycolipopeptide, for the early diagnosis of chronic berylliosis. Results in an experimental model of berylliosis in baboons. Br J Ind Med 49: 359–364.

    CAS  PubMed  Google Scholar 

  42. Diot P, Lemarie E, Baulieu JL, Pascal S, Vaillant L, Revillard JP, Binz H, Normier G, Le Pape A, (1992) Scintigraphy with J001X macrophage targeting glycolipopeptide: a new approach for sarcoidosis imaging. Chest 102: 670–676.

    Article  CAS  PubMed  Google Scholar 

  43. Chinet T, Dusser D, Labrune S, Collignon MA, Chretien J, Huchon G (1981) Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA. Am Rev Respir Dis 141: 445–449.

    Article  Google Scholar 

  44. Mason GR, Uszler JM, Effros RM, Reid E (1983) Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking. Chest 1: 6–11.

    Article  Google Scholar 

  45. Oberdorster G, Utell MJ, Morrow PE, Hyde RW, Weber DA (1986). Bronchial and alveolar absorption of inhaled 99mTc-DTPA. Am Rev Respir Dis 134: 944–950.

    CAS  PubMed  Google Scholar 

  46. Rinderknecht J, Shapiro L, Krauthammer M et al (1980) Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am Rev Respir Dis 121: 105–117.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. P. Diot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Lemarié
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Le Pape
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Peltier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Caillat-Vigneron
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag France

About this chapter

Cite this chapter

Diot, P., Lemarié, E., Le Pape, A., Peltier, P., Caillat-Vigneron, N. (1993). Diffuse interstitial lung diseases. In: Nuclear medicine and lung diseases. Springer, Paris. https://doi.org/10.1007/978-2-8178-0948-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0948-9_7

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0950-2

  • Online ISBN: 978-2-8178-0948-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation